 |
TOKYO, Jan. 28, 2025 /PRNewswire/ -- ThinkCyte, a biotechnology company pioneering novel artificial intelligence (AI)-based cell analysis and sorting instruments, announced today that it will begin the pre-commercial launch of its new cell analysis platform, VisionCyteâ„¢. The announcement coincides with the 2025 Society for Laboratory Automation and Screening (SLAS) conference in San Diego, CA from January 27-30, 2025, where VisionCyte was named a finalist for the 2025 New Product Award. The launch of VisionCyte extends ThinkCyte's product portfolio of life science research platforms beyond VisionSort, the company's flagship product launched in 2023 and adopted by leading biopharmaceutical companies and academic institutions worldwide.
The VisionCyte platform leverages high resolution morphological profiling, high-throughput capabilities, and advanced AI analysis to uncover novel biomarkers and facilitate the discovery of new and diversified hits and targets for drug discovery. The full commercial rollout of VisionCyte will occur in 2025, with an initial line of customer ready units available in H2 2025. The company also announced the launch of its Celluminate cell tracking kits, compatible with both VisionSort and VisionCyte, for enabling discovery applications in areas where existing cell surface cell markers are limited such as specific hematological conditions, stem cell research, and age-related diseases.
"The expansion of our product portfolio reflects our unwavering commitment to advancing life science research." said Waichiro Katsuda, Chief Executive Officer at ThinkCyte. "By introducing innovative solutions that address the evolving needs of scientists worldwide, we're not just adding products—we're providing the tools to accelerate discoveries in disease understanding and drug discovery to improve lives."
More information about the VisionCyte platform can be found by visiting the ThinkCyte booth (#2632) at SLAS 2025 or by visiting thinkcyte.com/visioncyte.
About ThinkCyte
ThinkCyte, founded in 2016 with offices in Tokyo, Japan and Redwood City, California is a biotechnology company that develops innovative scientific instruments based on integrated, multidisciplinary technologies to enable life science research, diagnostics, and therapeutic development. The company pioneered Ghost Cytometryâ„¢, a proprietary AI-based, label-free cell analysis and sorting technology and partners with major global biopharmaceutical companies and leading academic research institutes to drive pioneering research. For more information, please visit www.thinkcyte.com.
TOKYO, Jan. 28, 2025 /PRNewswire/ -- ThinkCyte, a biotechnology company pioneering novel artificial intelligence (AI)-based cell analysis and sorting instruments, announced today that it will begin the pre-commercial launch of its new cell analysis platform, VisionCyteâ„¢. The announcement coincides with the 2025 Society for Laboratory Automation and Screening (SLAS) conference in San Diego, CA from January 27-30, 2025, where VisionCyte was named a finalist for the 2025 New Product Award. The launch of VisionCyte extends ThinkCyte's product portfolio of life science research platforms beyond VisionSort, the company's flagship product launched in 2023 and adopted by leading biopharmaceutical companies and academic institutions worldwide.
The VisionCyte platform leverages high resolution morphological profiling, high-throughput capabilities, and advanced AI analysis to uncover novel biomarkers and facilitate the discovery of new and diversified hits and targets for drug discovery. The full commercial rollout of VisionCyte will occur in 2025, with an initial line of customer ready units available in H2 2025. The company also announced the launch of its Celluminate cell tracking kits, compatible with both VisionSort and VisionCyte, for enabling discovery applications in areas where existing cell surface cell markers are limited such as specific hematological conditions, stem cell research, and age-related diseases.
"The expansion of our product portfolio reflects our unwavering commitment to advancing life science research." said Waichiro Katsuda, Chief Executive Officer at ThinkCyte. "By introducing innovative solutions that address the evolving needs of scientists worldwide, we're not just adding products—we're providing the tools to accelerate discoveries in disease understanding and drug discovery to improve lives."
More information about the VisionCyte platform can be found by visiting the ThinkCyte booth (#2632) at SLAS 2025 or by visiting thinkcyte.com/visioncyte.
About ThinkCyte
ThinkCyte, founded in 2016 with offices in Tokyo, Japan and Redwood City, California is a biotechnology company that develops innovative scientific instruments based on integrated, multidisciplinary technologies to enable life science research, diagnostics, and therapeutic development. The company pioneered Ghost Cytometryâ„¢, a proprietary AI-based, label-free cell analysis and sorting technology and partners with major global biopharmaceutical companies and leading academic research institutes to drive pioneering research. For more information, please visit www.thinkcyte.com.
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
ThinkCyte expands product portfolio to drive innovation in drug discovery and disease research.
SHANGHAI, April 4, 2026 /PRNewswire/ -- From April 2 to 31, the Assembly Character Toys brand Blokees made its debut at the 2026 Thailand Toy Expo. Blokees unveiled its two major categories — Blokees Model Kits and Blokees Wheels, highlighting a diverse product matrix of more than 300 products across 17 globally recognized IPs, including Ultraman, Transformers, DC, Evangelion, Naruto, Minions, Jurassic World, Hatsune Miku, and Hero Infinity. Four new model kits also made their global debut, emerging as key highlights of the event.
Mario Maurer attended the opening ceremony of Blokees Thailand Toy Expo as a special guest and engaged in interactive exchanges with consumers.
In the Blokees Model Kits category, Blokees exhibited its Champion, Legend, and Fantastic Series, featuring popular IPs such as Transformers, DC, Mega Man, Saint Seiya, Evangelion, and Naruto. More than 50 products were presented to consumers. Among them, four newly launched items—including Blokees Saint Seiya-Champion Class-12-Phoenix Ikki, Blokees Saint Seiya-Champion Class-14-Andromeda Shun, Blokees DC-Champion Class 05-Batman (HUSH), and Blokees DC-Champion Class 06-Catwoman (Hush)—drew strong interest from fans.
Blokees also highlighted its HERO5 and HERO10 series, featuring well-known IPs including Transformers, Saint Seiya, and Naruto, catering to consumers of hero-themed collectible models.
The DaaLaMode series introduced a range of products inspired by popular IPs such as Hatsune Miku, appealing to female consumers. Meanwhile, the TERRAVENTURE series presented nature and creature-themed model kits based on Jurassic World, further expanding Blokees' offerings across different consumer segments.
In the Blokees Wheels category, which integrates construction, play, and customization, products are organized into the C, E, and S series. The lineup includes IP-based offerings from Transformers, Ultraman, and Batman, with upcoming collaborations featuring Fast & Furious and Ford.
In addition, Blokees highlighted its global consumer ecosystem, BFC (Blokees Family Creator). Selected works from 2025 The 3rd BFC Creation Contest Stellar Season were exhibited in Thailand for the first time, reflecting strong user creativity and engagement. 2026 The 4th BFC Creation Contest Season of Awakening has officially launched, further encouraging global participation.
Under its "Universally appealing, Stepwise pricing, Globally promoting" strategy, Blokees continues to expand across Southeast Asia, Europe, North America, and Latin America. Thailand is rapidly becoming a strategic hub in its regional expansion, as the company strengthens both product innovation and community-driven growth worldwide.
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
Blokees made its debut at 2026 Thailand Toy Expo, exhibiting multiple products
